The pathway “FTO obesity variant mechanism” is relevant to the T2D phenotype as SNPs in the Fat mass and Obesity-associated (FTO) gene have been found to be associated with adiposity and risk of obesity in multiple populations [43]. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.